Enumeral has raised $21.5 million in a private placement. According to terms of the transaction, the company sold 21.5 million shares at a price of $1 per share. Montrose Capital Partners led the financing with participation from founding investor Harris & Harris Group. Intuitive Venture Partners served as exclusive financial advisor while EDI Financial was the lead placement agent. Based in Cambridge, Mass., Enumeral develops developing antibody immunotherapies that help the immune system attack diseased cells. The company just completed a merger between Enumeral Biomedical Corp and a unit of Enumeral Biomedical Holdings (formerly known as Cerulean Group).
I currently bootstrap @Hackyourstyle, @Syntezia and @Agilenetup. I also help @panglosslabs1 @lepole.education and @yoursoftweb. My passion is to help scale ups and corporates stay creative, innovative and up to date with new business models. I specialise in rapid prototyping, competitive intelligence, open innovation and strategic agility. We follow the latest developments in social media, cloud computing, in 3D (printing, scan, manufacturing) in mobile apps and games, as well as in big data. semantics, text analytics and HR analytics technologies. We have developed a special interest the Open Education trends and what happens with the MOOCs. As a Corporate Responsability Ambassador, I regurlarly talk about ethics as a conference speaker, or as a moderator, and I have recently been awarded as "Equal Salary Ambassador". I am active on Twitter, Facebook, Github, Google+, Pinterest, Quora, Instagram, Persiscope and LinkedIN, you can find all the links in the Contact section. Very keen to interact with you.